NVD003
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NVD003, covering 2024-03-28 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia. [Phase 3]